| Literature DB >> 28062688 |
Chunlong Xu1, Xiaolan Qi1, Xuguang Du1, Huiying Zou1, Fei Gao1, Tao Feng1, Hengxing Lu1, Shenglan Li2,3, Xiaomeng An1, Lijun Zhang1, Yuanyuan Wu4, Ying Liu2,3,5, Ning Li1, Mario R Capecchi6, Sen Wu7.
Abstract
CRISPR/Cas9 is becoming an increasingly important tool to functionally annotate genomes. However, because genome-wide CRISPR libraries are mostly constructed in lentiviral vectors, in vivo applications are severely limited as a result of difficulties in delivery. Here, we examined the piggyBac (PB) transposon as an alternative vehicle to deliver a guide RNA (gRNA) library for in vivo screening. Although tumor induction has previously been achieved in mice by targeting cancer genes with the CRISPR/Cas9 system, in vivo genome-scale screening has not been reported. With our PB-CRISPR libraries, we conducted an in vivo genome-wide screen in mice and identified genes mediating liver tumorigenesis, including known and unknown tumor suppressor genes (TSGs). Our results demonstrate that PB can be a simple and nonviral choice for efficient in vivo delivery of CRISPR libraries.Entities:
Keywords: CRISPR/Cas9; liver cancer; piggyBac transposon; screening; tumorigenesis
Mesh:
Substances:
Year: 2017 PMID: 28062688 PMCID: PMC5278437 DOI: 10.1073/pnas.1615735114
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205